Previous studies have demonstrated that different levels of kalirin in SMCs, endothelial cells, and monocytes lead to different functions in injured arteries; consequently, the serum kalirin level might be an early marker for preatherosclerotic intimal hyperplasia. This evidence concerns the gene KALRN and hyperplasia.